The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...
New Delhi: The Union government is drawing up an index to gauge states and union territories on their preparedness to enforce ...
Bushra Sumra’s career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...
The government is expected to extend the deadline for small drug companies to comply with the revised Schedule M standards ...
Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...
Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...
The debate over pharmaceutical advertising on television has resurfaced with renewed vigor, among populist conservatives and activists, such ...
Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory approval during the first quarter of next year, slightly later than its previous ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...
While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.